| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
37,967 |
34,215 |
$1.79M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,073 |
7,229 |
$565K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
5,058 |
4,598 |
$538K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,542 |
3,234 |
$87K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,400 |
1,675 |
$43K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,915 |
2,642 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
292 |
260 |
$11K |
| 87631 |
|
142 |
123 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,165 |
1,038 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
76 |
68 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
145 |
136 |
$3K |
| 2015F |
|
62 |
61 |
$1K |
| 81003 |
|
549 |
517 |
$960.14 |
| 0001A |
|
36 |
32 |
$846.57 |
| 99051 |
|
12,618 |
11,090 |
$571.70 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
89 |
85 |
$264.64 |
| 81002 |
|
477 |
310 |
$151.90 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
13 |
$28.80 |
| 81025 |
|
15 |
12 |
$18.48 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
160 |
143 |
$10.61 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
125 |
111 |
$8.63 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
15 |
13 |
$0.96 |